Loading...
Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer
BACKGROUND: The outcome of patients with metastatic colorectal carcinoma (mCRC) following first line therapy is poor, with median survival of less than one year. The purpose of this study was to identify candidate therapeutically targetable somatic events in mCRC patient samples by whole genome sequ...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4074842/ https://ncbi.nlm.nih.gov/pubmed/24943349 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-8794-7-36 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|